Solana Co — Director's Dealing 2021

Jul 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2021-07-07

Reporting Person: Favit-Van Pelt Antonella R. (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-07	Stock Option (Right to Buy)	$16.45	A	18000	Acquired	2031-07-06	Common Stock (18000)	Direct

Footnotes

F1: Grant to the Reporting Person of a stock option under the Issuer's 2021 Inducement Plan. The options vest in four equal installments on each of the first, second, third and fourth anniversaries of the date of grant, subject to the Reporting Person's continued service through each applicable vesting date.